A look at a High Market Cap Stock: Boston Scientific Corporation, BSX

Boston Scientific Corporation, BSX is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Boston Scientific Corporation, BSX has a market cap of 31880.85. Since its IPO date on the 5/19/1992, Boston Scientific Corporation, BSX performance year to date is 26.41%. Today Boston Scientific Corporation, BSX has gained -0.85%, with a current price of 23.31.

Ownership of the company is 0.40% for insider ownership while institutional ownership is 94.20%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at -1.90%, with return on investment at 0.70%.

In terms of debt levels and profit levels, Boston Scientific Corporation, BSX is seeing a long-term debt/equity of 0.83. While Total debt/equity is 0.87. With a profit margin of -4.30%, this is combined with a gross margin of 71.10%, and operating margin of -7.70%. Boston Scientific Corporation ability to meet debt levels, with a current ratio of 1, while the quick ratio is 0.7.

For the last year Boston Scientific Corporation, BSX has seen a EPS growth of -98.30%. A performance for the year of 39.41%. The 52-week high is -5.97%, and the 52-week low is 48.76%. The average volume for Boston Scientific Corporation, BSX is 12077300.

With a target price of *TBA, can Boston Scientific Corporation, BSX reach this target? Looking at the value indicators of Boston Scientific Corporation, BSX. Boston Scientific Corporation has a P/E of *TBA and a forward P/E of 18.53. Perhaps the more useful indicator than P/E, is PEG which has a value of *TBA. Boston Scientific Corporation also has a P/S and a P/B of 4.01 and 5.09 respectively. For P/cash, Boston Scientific Corporation has a value of 72.79, while it is 44.46 for P/free cash flow.

At the current price of 23.31, Boston Scientific Corporation has a dividend yield of *TBA. We see a return on equity of -5.40%.

Looking more long-term Boston Scientific Corporation, is projected to get an EPS growth for the next five years of 13.07%. In the short-term an EPS growth of 14.26% in the next year is forecasted. This is after a EPS growth of -98.30% for this year and for the last five years a 24.00% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.